PLT、D-D和PAB水平对肝癌患者病情及预后的预测价值OA
Predictive value of PLT,D-D,and PAB levels for disease severity and prognosis in patients with liver cancer
目的 分析血小板(PLT)、D-二聚体(D-D)、前白蛋白(PAB)水平对肝癌患者病情及预后的预测价值,以期为肝癌的个体化治疗及预后分层提供新的参考依据.方法 选取 2023 年 1 月—2025 年 1 月空军军医大学西京医院第九八六医院收治的 120 例肝癌患者为研究对象,依据 TNM 分期分为Ⅰ~Ⅱ期组(n=72)和Ⅲ~Ⅳ期组(n=48),依据 6 个月预后分为预后不良组(n=40)和预后良好组(n=80).入院后测定患者的血清 PLT、D-D、PAB 水平,采用 logistic 回归分析构建PLT、D-D 及 PAB 联合预测模型,采用受试者工作特征(ROC)曲线分析 PLT、D-D 及 PAB 水平单独检测及联合检测对肝癌患者病情进展及预后的预测效能.结果 Ⅲ~Ⅳ期组患者的血清 PLT、D-D 水平高于Ⅰ~Ⅱ期组,PAB 水平低于Ⅰ~Ⅱ期组,差异均有统计学意义(P<0.05);预后不良组患者的血清 PLT、D-D 水平高于预后良好组,PAB 水平低于预后良好组,差异均有统计学意义(P<0.05).logistic 回归分析结果显示,血清 PLT、D-D 水平升高及 PAB 水平降低是肝癌患者病情进展及预后的危险因素(P<0.05).ROC 曲线分析结果显示,血清 PLT、D-D 及 PAB 水平联合检测预测肝癌患者病情进展的曲线下面积(AUC)为 0.866(95%CI:0.792~0.922),高于各指标单独检测(Z=3.753,2.368,3.380,均 P<0.05);血清 PLT、D-D 及 PAB 水平联合检测预测肝癌患者预后的 AUC 为 0.874(95%CI:0.801~0.927),高于各指标单独检测(Z=3.263、2.465、2.895,均 P<0.05).结论 PLT、D-D 及 PAB 水平检测对肝癌患者病情及预后具有一定的预测价值,且三者联合检测可提升预测效能,故临床应早期监测 PLT、D-D 及 PAB 水平,以便采取个体化精准治疗,从而改善患者预后.
Objective To analyze the predictive value of platelet(PLT),D-dimer(D-D),and prealbumin(PAB)levels for disease severity and prognosis in patients with liver cancer,so as to provide a new reference for individualized treatment and prognostic stratification of liver cancer.Methods A total of 120 patients with liver cancer admitted to Xijing 986 Hospital,Air Force Medical University,from January 2023 to January 2025 were selected as study participants.According to TNM stage,they were assigned to a stage Ⅰ-Ⅱ group(n=72)and a stage Ⅲ-Ⅳ group(n=48).According to prognosis at the 6-month follow-up,they were assigned to a poor prognosis group(n=40)and a good prognosis group(n=80).Serum PLT,D-D,and PAB levels were measured after admission.Logistic regression analysis was used to construct a combined prediction model of PLT,D-D,and PAB.Receiver operating characteristic(ROC)curves were used to analyze the predic-tive performance of individual and combined detection of PLT,D-D,and PAB levels for disease progression and prognosis in these patients.Results Serum PLT and D-D levels in the stage Ⅲ-Ⅳ group were higher than those in the stage Ⅰ-Ⅱgroup,while PAB level was lower than that in the stage Ⅰ-Ⅱ group,with statistically significant differences(P<0.05).Serum PLT and D-D levels in the poor prognosis group were higher than those in the good prognosis group,while PAB level was lower than that in the good prognosis group,with statistically significant differences(P<0.05).Logistic regression a-nalysis showed that elevated serum PLT and D-D levels and decreased PAB level were risk factors for disease progression and prognosis in patients with liver cancer(P<0.05).ROC curve analysis showed that the area under the curve(AUC)of combined detection of serum PLT,D-D,and PAB levels for predicting disease progression in patients with liver cancer was 0.866(95%CI:0.792-0.922),which was higher than that of each single indicator(Z=3.753,2.368,3.380;P<0.05).The AUC of combined detection for predicting prognosis was 0.874(95%CI:0.801-0.927),which was higher than that of each single indicator(Z=3.263,2.465,2.895;P<0.05).Conclusion Detection of PLT,D-D,and PAB levels has certain predictive value for disease severity and prognosis in patients with liver cancer,and their combined detection can im-prove predictive performance.Therefore,early monitoring of PLT,D-D,and PAB levels is recommended in clinical practice to facilitate individualized precision treatment and improve patient prognosis.
成晓梅;王钧;武李红;王翠翠;贺静雅;乔亚琴;王进海;荆玉洁
空军军医大学西京医院第九八六医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054西安交通大学第二附属医院消化内科,西安 710054空军军医大学西京医院第九八六医院消化内科,西安 710054
医药卫生
肝癌血小板D-二聚体前白蛋白病情预后预测价值
Liver cancerPlateletD-dimerPrealbuminDisease severityPrognosisPredictive value
《保健医学研究与实践》 2026 (7)
44-51,8
陕西省重点研发计划项目(2023-YBSF-485).
评论